[Paclitaxel in therapy of breast carcinoma. Value and perspectives]

Med Klin (Munich). 1996 Dec 15:91 Suppl 2:7-10.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents, Phytogenic / adverse effects
  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology
  • Clinical Trials as Topic
  • Female
  • Humans
  • Neoplasm Staging
  • Paclitaxel / adverse effects
  • Paclitaxel / therapeutic use*
  • Survival Rate

Substances

  • Antineoplastic Agents, Phytogenic
  • Paclitaxel